Milestones

1. Luque M, Martínez MÁ, Insenser M, Fernández E, Quintero A, Fiers T, Kaufman JM, García AM, Rosillo M, Nattero L, Escobar HF. Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting. J Endocrinol Invest. 2024;DOI:10.1007/s40618-024-02416-0. This paper discusses the diagnostic methods of polycystic ovary syndrome (PCOS). In conclusion, immunoassays used in clinical practice are inaccurate for phenotyping women with PCOS.
2. Nattero L, Insenser M, Amigó N, Samino S, Martínez N, Dorado B, Quintero A, Escobar HF, Luque M. Quantification of lipoproteins by proton nuclear magnetic resonance spectroscopy ((1)H-NMRS) improves the prediction of cardiac autonomic dysfunction in patients with type 1 diabetes. J Endocrinol Invest. 2024;47(8): 2075 - 2085. DOI:10.1007/s40618-023-02289-9. This paper describes how the advanced lipoprotein profile determined by magnetic resonance imaging (MRI), together with clinical variables, is useful to identify patients with type 1 diabetes at risk of cardioautonomic neuropathy (CAN).
3. Martínez MÁ, Quintero A, de Lope S, Insenser M, Fernández E, Escobar HF, Luque M. Obesity and polycystic ovary syndrome influence fasting intestinal permeability and modify the effect of various macronutrients on the intestinal barrier. ALIMENTACIÓN RES INT. 2024;186: 114338 - 114338. DOI:10.1016/j.foodres.2024.114338. This work shows that obesity and PCOS alter the effect of macronutrients on the intestinal barrier and affect fasting intestinal permeability, promoting endotoxemia and chronic inflammation in functional hyperandrogenism.
4. Awards for the best article, doctoral thesis, and a research grant were awarded at the 65th Congress of the Spanish Society of Endocrinology and Nutrition (SEEN), held in Oviedo. These recognitions reinforce the research group's distinguished track record in research and clinical excellence.
5. National multidisciplinary conference on type 1 diabetes. First edition of these conferences, which aim to update knowledge on research, innovation, and technological development in the field of type 1 diabetes.